Grantham, Mayo, Van Otterloo & Co (GMO)’s Quanex NX Stock Holding History
Bought
Maintained
Sold
Other funds holding NX
SBH
SFM
Grantham, Mayo, Van Otterloo & Co (GMO)'s NX Position: Q2 2023 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Quanex (NX) in Q2 2023, closing a stake of 11,300 shares — an estimated $243K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NX in Q1 2019 and held it in 14 quarters. The position peaked at $1.36M in Q2 2019. 159 funds tracked by Wall St. Rank hold NX as of Q2 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Quanex position as of Q2 2023 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,300 Quanex shares in Q2 2023, an estimated $243K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Quanex in Q1 2019 and held it in 14 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Quanex position peaked at $1.36M in Q2 2019.
- 159 funds tracked by Wall St. Rank held Quanex as of Q2 2023.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.